Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that hirsutism in women can be managed with hair removal techniques, medications, and topical treatments.

DHEA supplementation may improve quality of life, neuropsychological functions, and sexual satisfaction in individuals with adrenal insufficiency, but more research is needed to confirm its safety and effectiveness.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

SHBG may be a useful early indicator and treatment target for PCOS.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

A woman with a rare adrenal tumor and hormonal disorder had improved testosterone levels after surgery, but her menstrual irregularities continued.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Polycystic ovary syndrome (PCOS) affects about 10% of women, is often linked to obesity and family history, and can cause irregular periods, fertility issues, and other symptoms. It's usually managed with lifestyle changes, weight loss, and medication.

A 16-year-old girl with HAIR-AN syndrome was treated with lifestyle changes and medications to manage her condition.

A woman with a rare ovarian tumor and hyperparathyroidism improved after surgery, highlighting the need for reporting unusual cases to understand and manage rare diseases.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Diagnosing and treating PCOS in young people is difficult.

Minoxidil is better for female hair loss without hormonal issues, cyproterone acetate for those with; people with treated congenital heart disease have lower life quality; personality differs in types of infertility; oral terbinafine is best for toenail fungus; bladder training reduces incontinence; nurse clinics help with heart disease; weight loss improves body composition and liver disease; computer training cuts drug errors.

Common hair loss can be diagnosed with a physical exam and sometimes a hair test or skin biopsy, and treated with medication or surgery, with ongoing treatment needed to keep results.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

Treatment improved symptoms in a woman with HAIR-AN syndrome.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

Lab tests for female hair loss have unclear usefulness; consider based on symptoms.

Using a combined treatment of minoxidil and metformin can improve hair loss in women by normalizing hormone and metabolism levels.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Women with excessive hair growth or polycystic ovary disease may more often carry a gene variant for 21 hydroxylase deficiency.